Advanced Medical Solutions Group (LON:AMS) Stock Price Passes Above 200-Day Moving Average – Time to Sell?

Advanced Medical Solutions Group plc (LON:AMS) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 212.83 and traded as high as GBX 224.50. Advanced Medical Solutions Group shares last traded at GBX 223.48, with a volume of 1,393,094 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Berenberg Bank reiterated a “buy” rating and issued a GBX 300 target price on shares of Advanced Medical Solutions Group in a research note on Thursday, January 15th. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of GBX 273.67.

Advanced Medical Solutions Group Stock Performance

The business has a 50 day moving average of GBX 215.85 and a 200-day moving average of GBX 212.83. The company has a market capitalization of £483.62 million, a P/E ratio of 53.60, a price-to-earnings-growth ratio of 5.00 and a beta of 0.74. The company has a debt-to-equity ratio of 37.01, a quick ratio of 4.58 and a current ratio of 8.39.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.